Jan Sebek, research assistant professor in the Mike Wiegers Department of Electrical and Computer Engineering at Kansas State University, works in the Biomedical Computing and Devices Laboratory directed by Punit Prakash. Prakash’s research team helped develop a bronchoscopic microwave ablation treatment now in the clinical study phase in Australia that could allow for the treatment of small lung tumors via a single-session procedure that would also improve patient safety and reduce cost. (Courtesy photo)

Researchers at Kansas State University have developed an improved treatment for lung cancer.

According to a university release Tuesday, project collaborators recently completed the first procedure in Australia as part of a clinical study. The procedure involves improved bronchoscopic microwave ablation treatment which officials hope could treat small lung tumors.

K-State collaborated with Royal Melbourne Hospital, phenoMapper LLC and Australian Healthcare Solutions on the clinical study, which was reportedly “straightforward and required skills that all interventional pulmonologists would possess,” according to Royal Melbourne professor of medicine Daniel Steinfort.

The phenoWave system’s underlying technology was jointly developed by the research team led by K-State engineer Punit Prakash and industry partner phenoMapper LLC under a National Cancer Institute academic-industry partnership R01 grant.

The phenoWave microwave ablation system will enable physicians to diagnose and treat lesions in the lungs in a single session, improving patient safety and reducing costs. The underlying technology for the system was jointly developed by a K-State research team led by Punit Prakash and industry partner phenoMapper LLC. (Courtesy photo)

The post K-State researchers announce clinical study for improved lung cancer treatment appeared first on News Radio KMAN.